virginia catalyst
  • Home
  • Grant Funding
    • Apply for Funding
    • History of Awards
    • Downloads
    • FAQ
  • News
  • About
    • Our Team
    • Contact Us
    • Terms & Conditions
    • Privacy
  • Home
  • Grant Funding
    • Apply for Funding
    • History of Awards
    • Downloads
    • FAQ
  • News
  • About
    • Our Team
    • Contact Us
    • Terms & Conditions
    • Privacy
901 E. Cary Street
Suite 900
Richmond, Virginia

(804) 545-5799

History of Awards

Grant Round 12 - October 2021

Optimization and Commercialization of Environmentally-Sustainable Biofungicides
Virginia Tech, University of Virginia
AgroSpheres, Inc. (Charlottesville, VA)

$600,000

Design Automation for Scaled Manufacturing of Advanced Custom Orthopedic Braces
University of Virginia, Virginia Commonwealth University
Icarus Medical Innovations (Charlottesville, VA)
$600,000

Pilot Study to Evaluate a Nonsurgical Gel Patch for Eardrum Repair in Human Patients
Eastern Virginia Medical School, Virginia Commonwealth University
Tympanogen, Inc. (Richmond, VA)

$737,369

Grant Round 11 - October 2020

​​Clinical Translation of a Male Contraceptive Procedure
University of Virginia, Virginia Commonwealth University
Contraline, Inc. (Charlottesville, VA)

$600,000

Treating Chronic Disease Caused by Microbiome Dysbiosis
George Mason University, Eastern Virginia Medical School
ISOThrive, Inc. (Manassas, VA)
$800,000

Innovative Bioanalytical Instrument for Improving Drug Discovery
Virginia Commonwealth University, Old Dominion University
Meru Biotechnologies (Richmond, VA)

$700,000

Grant Round 10 - January 2020

​Microsystem for Label-Free Separation and Recovery of Tumor-Associated Cells
from Biopsies for Precision Medicine

Virginia Tech, University of Virginia
CytoRecovery Inc. (Blacksburg, VA)

$400,000

Commercializing a Novel Treatment for Metastatic Cancers
Virginia Commonwealth University, University of Virginia
InterLeukin Combinatorial Therapies Inc. (Richmond, VA)

$700,000

Design and Implementation of Green, Enzymatic Biofungicides for
Pre- and Post-Harvest Crop Protection

University of Virginia, Virginia Tech
Lytos Technologies LLC (Charlottesville, VA)
$500,000
​
Protein Painting of PD-1/PD-L1 for the Discovery of New Immune Checkpoint Inhibitors
​for the Treatment of Lung Cancer and Brain Metastasis

George Mason University, Virginia Tech
Monet Pharmaceuticals (Nokesville, VA)
$400,000


Automated 3D Spinal Navigation System for Bedside Lumbar Puncture Procedures
University of Virginia, Virginia Commonwealth University
RIVANNA (Charlottesville, VA)

$800,000
​
Development of an Applicator and Training Simulator for a Gel Patch for Nonsurgical Eardrum Repair
Eastern Virginia Medical School, Virginia Commonwealth University
Tympanogen (Richmond, VA)

$500,000

Grant Round 9 - May 2019

​Agrospheres-Enabled Biological Fungicide
Virginia Tech, University of Virginia
AgroSpheres Inc. (Charlottesville, VA)
$600,000

Rapid Drug Development Using Molecular Rotational Resonance (MRR) for Structure Analysis
Virginia Commonwealth University, University of Virginia, Virginia Tech
BrightSpec Inc. (Charlottesville, VA)

$400,000

Nanotrap Liquid Biopsy Collection Device (LBC) for Cancer Diagnostics
University of Virginia, George Mason University
Ceres Nanosciences Inc. (Manassas, VA)
$600,000
​
Implementation and Clinical Impact of a Next Generation Precision Oncology Platform
University of Virginia, Eastern Virginia Medical School
Perthera Inc. (McLean, VA)
$500,000

Grant Round 8 - May 2018

MRR: A Major New Chiral Analysis Technique for Drug Discovery, Development and Process Control
Virginia Commonwealth University, Virginia Tech, University of Virginia
BrightSpec Inc. (Charlottesville, VA)
$400,000

Safe Mitochondrial Uncouplers for the Treatment of Human Disease
Virginia Tech, University of Virginia
Continuum Biosciences Inc. (Blacksburg, VA)
$400,000
​​
Biofabrication of Regenerative Musculoskeletal Therapeutics
Old Dominion University, University of Virginia
Embody Inc. (Norfolk, VA)
$800,000

Tissue Preparations for Therapeutic Use in Cardiovascular Applications
Old Dominion University, Eastern Virginia Medical School
LifeNet Health (Virginia Beach, VA)
$250,000

Novel Anti-Inflammatory Drug with Strong Neuroprotective Properties for Treatment of Traumatic Brain Injury (TBI)
Virginia Commonwealth University, George Mason University
Serpin Pharma (Manassas, VA)
$350,000

Preventing Catheter Associated Infections
Virginia Commonwealth University, University of Virginia
WynnVision LLC (Richmond, VA)
$510,000

Grant Round 7 - July 2017

Virginia Brain Injury Diagnosis and Monitoring Initiative
Virginia Tech, University of Virginia
BRAINBox Solutions, Inc. (Richmond, VA)
$500,000
​
Novel Preventive Treatment Paradigm to Change the Standard of Care for Those Who Recover from Opioid Overdose
Virginia Commonwealth University, Virginia Tech, George Mason University/ Inova
Indivior, Inc. (Richmond, VA)
​$500,000

Development of Peptide Inhibitor of Complement C1 as a treatment for neonatal hypoxic-ischemic encephalopathy
Eastern Virginia Medical School, Virginia Commonwealth University
ReAlta Life Sciences, Inc. (Norfolk, VA)
$400,000

Grant Round 6 - October 2016

BT-11: First-in-class oral therapeutic for IBD
Virginia Tech, Virginia Commonwealth University
BioTherapeutics, Inc. (Blacksburg, VA)
VT, VCU

$800,000

Bioengineering for the therapeutic delivery of massively expanded islet-derived human beta-cells
Virginia Commonwealth University, University of Virginia
Propagenix, Inc. (Rockville, MD) 

$425,000

Translational research with nanosecond pulsed electric fields for immuno-oncology applications
Old Dominion University, Eastern Virginia Medical School
Pulse Biosciences, Inc. (Burlingame, CA)

$300,000

Accelerating the commercialization of the Diamond™ mouse model of NASH
Eastern Virginia Medical School, George Mason University
Sanyal Biotechnology (Richmond, VA)

$100,000

Novel and potent anti-inflammatory drug with cardio-protective effects to treat myocardial injury and prevent heart failure
George Mason University, Virginia Commonwealth University
Serpin Parma (Manassas, VA)

$400,000

Commercialization of INSPIRE brain cancer treatment
Virginia Tech, University of Virginia
VoltMed, Inc. (Blacksburg, VA)

$800,000

Grant Round 5 - December 2015

Development of a biomarker assay and protocol for the commercialization of mibefradil dihydrochloride as a first-line treatment for glioblastoma
University of Virginia, George Mason University, Yale University
Cavion, LLC (Charlottesville, VA)

$307,057

INSPIRE to fight brain cancer
Virginia Tech, University of Virginia
VoltMed, Inc. (Blacksburg, VA)
$380,000

Grant Round 4 - August 2015

Three wave mixing technique for chiral analysis in continuous process manufacturing
Virginia Commonwealth University, University of Virginia
BrightSpec Inc. (Charlottesville, VA)
$400,000

Optimizing oral delivery of BT-11 as a clinical candidate for treating inflammatory bowel disease
Virginia Tech, Virginia Commonwealth University
BioTherapeutics, Inc. (Blacksburg, VA)
$400,000

Nanotrap® tick-panel test development
George Mason University, Virginia Tech
Ceres Nanosciences Inc. (Manassas, VA)
$500,000

Nanofabrication of tissue scaffolds
Old Dominion University, Eastern Virginia Medical School
Embody, Inc. (Norfolk, VA)

$634,500

Clinical trial of new drug in dogs to treat brain cancer in humans
Virginia Tech, University of Virginia
FirstString Research

$290,000

Grant Round 3 - August 2014

PhenoCHIP-phenotype-based cell hierarchy and isolation platform
Virginia Tech, University of Virginia
Proteo Biosciences

$270,000

​Biomarker-driven optimization of IL-12 gene electrotransfer for the treatment of melanoma
Old Dominion University, Eastern Virginia Medical School
Onosec Medical

$585,000

Ultrasonographic probe
Virginia Commonwealth University, Old Dominion University
Ultrasonic Probe

$536,000

Grant Round 2 - March 2014 

Reversing bioenergetic deficits and improving cognitive function in Alzheimer’s Disease
Virginia Commonwealth University, University of Virginia
Gencia Corporation

$400,000

Enhancement of healing in diabetic wounds using a decellularized dermal matrix
Eastern Virginia Medical School, University of Virginia
LifeNet Health (Virginia Beach, VA)
$255,000

UVA-VCU partnership to develop radioimmunotherapeutic and imaging agents to a unique cell-surface target relevant for multiple human cancers
University of Virginia, Virginia Commonwealth University
Neoantigenics

$348,729

Lead optimization of a SphK2 inhibitor for the treatment of CKD
Virginia Tech, University of Virginia
SphynKx

$400,000

Grant Round 1 - December 2013

Development of novel anti-inflammatory drugs
Virginia Tech, Virginia Commonwealth University
BioTherapeutics, Inc. (Blacksburg, VA)
$400,000

Commercialization of a human tumor microenvironment system for pharmaceutical cancer drug discovery and development
University of Virginia, George Mason University
HemoShear Therapeutics, Inc. (Charlottesville, VA)

$450,000

Novel regenerative drug
Virginia Tech, University of Virginia
FirstString Research (Mount Pleasant, SC)

$200,000

Determining the optimal dosing schedule for the commercialization of mibefradil in front-line glioblastoma
University of Virginia, Virginia Commonwealth University
Tau Therapeutics: now
Cavion, LLC (Charlottesville, VA)
$200,000
Home
Terms & Conditions
​Privacy
Picture
Contact Us
Mike Grisham, CEO
(804) 543-5200
mgrisham@virginiacatalyst.org
  • Home
  • Grant Funding
    • Apply for Funding
    • History of Awards
    • Downloads
    • FAQ
  • News
  • About
    • Our Team
    • Contact Us
    • Terms & Conditions
    • Privacy